14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.95 $1.79 Friday, 3rd May 2024 NKTR stock ended at $1.57. This is 5.99% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 12.26% from a day low at $1.55 to a day high of $1.74.
90 days $0.540 $1.79
52 weeks $0.413 $1.79

Historical Nektar Therapeutics prices

Date Open High Low Close Volume
May 03, 2024 $1.73 $1.74 $1.55 $1.57 1 139 593
May 02, 2024 $1.71 $1.79 $1.59 $1.67 2 474 971
May 01, 2024 $1.45 $1.65 $1.45 $1.65 1 713 548
Apr 30, 2024 $1.45 $1.52 $1.40 $1.46 813 548
Apr 29, 2024 $1.35 $1.53 $1.35 $1.46 1 606 796
Apr 26, 2024 $1.33 $1.38 $1.31 $1.32 558 779
Apr 25, 2024 $1.36 $1.37 $1.29 $1.32 1 053 167
Apr 24, 2024 $1.37 $1.42 $1.37 $1.38 956 705
Apr 23, 2024 $1.39 $1.43 $1.31 $1.42 1 100 016
Apr 22, 2024 $1.30 $1.41 $1.29 $1.36 1 968 603
Apr 19, 2024 $1.33 $1.33 $1.20 $1.24 3 240 877
Apr 18, 2024 $1.32 $1.36 $1.27 $1.32 2 563 796
Apr 17, 2024 $1.48 $1.50 $1.28 $1.35 3 257 822
Apr 16, 2024 $1.47 $1.58 $1.45 $1.49 1 577 347
Apr 15, 2024 $1.68 $1.70 $1.50 $1.57 2 844 981
Apr 12, 2024 $1.58 $1.68 $1.48 $1.67 4 817 936
Apr 11, 2024 $1.37 $1.75 $1.36 $1.58 13 048 816
Apr 10, 2024 $1.20 $1.39 $1.16 $1.29 4 509 395
Apr 09, 2024 $1.30 $1.34 $1.24 $1.25 1 690 318
Apr 08, 2024 $1.34 $1.40 $1.22 $1.31 3 134 516
Apr 05, 2024 $1.32 $1.47 $1.26 $1.32 5 017 866
Apr 04, 2024 $1.08 $1.39 $1.08 $1.32 11 099 618
Apr 03, 2024 $0.98 $1.13 $0.95 $1.04 3 262 771
Apr 02, 2024 $0.90 $1.02 $0.90 $0.95 3 315 127
Apr 01, 2024 $0.93 $0.95 $0.90 $0.90 1 192 105
Click to get the best stock tips daily for free!

About Nektar Therapeutics

Nektar Therapeutics Nektar Therapeutics, a biopharmaceutical company, focuses on discovering and developing medicines in areas of unmet medical need in the United States and internationally. The company's products include Bempegaldesleukin, a CD122-preferential interleukin-2 (IL-2) pathway agonist, which is in phase 3 clinical trial to treat metastatic melanoma, renal cell carcinoma, muscle-invasive bladder cancer, squamous cell carcinoma of the head and neck, and a... NKTR Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT